Poor maternal nutrition and accelerated postnatal growth induces an accelerated aging phenotype and oxidative stress in skeletal muscle of male rats
暂无分享,去创建一个
C. Aiken | S. Ozanne | I. Hargreaves | J. Tarry-Adkins | D. Fernandez‐Twinn | V. Neergheen | Jian-hua Chen
[1] M. M. Torrejais,et al. Maternal protein restriction during pregnancy and lactation affects the development of muscle fibers and neuromuscular junctions in rats , 2017, Muscle & nerve.
[2] C. Aiken,et al. Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth1 , 2015, The American journal of clinical nutrition.
[3] E. Zambrano,et al. Maternal Obesity: Lifelong Metabolic Outcomes for Offspring from Poor Developmental Trajectories During the Perinatal Period. , 2016, Archives of medical research.
[4] M. Nijland,et al. Reduced placental amino acid transport in response to maternal nutrient restriction in the baboon. , 2015, American journal of physiology. Regulatory, integrative and comparative physiology.
[5] R. Brancalhão,et al. Effects of aging and maternal protein restriction on the muscle fibers morphology and neuromuscular junctions of rats after nutritional recovery. , 2015, Micron.
[6] M. Patti,et al. Low birth weight is associated with adiposity, impaired skeletal muscle energetics, and weight loss resistance in mice , 2014, International Journal of Obesity.
[7] M. Chinapaw,et al. The association of birth weight and infant growth with physical fitness at 8–9 years of age—the ABCD study , 2014, International Journal of Obesity.
[8] A. Perl,et al. Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus. , 2014, Antioxidants & redox signaling.
[9] S. Ozanne,et al. The impact of early nutrition on the ageing trajectory , 2014, Proceedings of the Nutrition Society.
[10] Karsten Keller,et al. Strength and muscle mass loss with aging process. Age and strength loss. , 2019, Muscles, ligaments and tendons journal.
[11] M. Cesari,et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. , 2013, The international journal of biochemistry & cell biology.
[12] U. Liebert,et al. Activity Increase in Respiratory Chain Complexes by Rubella Virus with Marginal Induction of Oxidative Stress , 2013, Journal of Virology.
[13] Yu-Ting Wu,et al. Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging , 2013, Experimental biology and medicine.
[14] C. Aiken,et al. Poor maternal nutrition followed by accelerated postnatal growth leads to alterations in DNA damage and repair, oxidative and nitrosative stress, and oxidative defense capacity in rat heart , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] P. Ray,et al. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.
[16] Pat Monaghan,et al. Telomere length in early life predicts lifespan , 2012, Proceedings of the National Academy of Sciences.
[17] C. Cooper,et al. Developmental influences, muscle morphology, and sarcopenia in community-dwelling older men. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[18] Michael J Morgan,et al. Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.
[19] O. Mortensen,et al. A maternal low protein diet has pronounced effects on mitochondrial gene expression in offspring liver and skeletal muscle; protective effect of taurine , 2010, Journal of Biomedical Science.
[20] C. Cooper,et al. The developmental origins of sarcopenia: from epidemiological evidence to underlying mechanisms. , 2010, Journal of developmental origins of health and disease.
[21] J. Baeyens,et al. European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .
[22] P. Hanson,et al. Edinburgh Research Explorer Mitochondrial Changes within Axons in Multiple Sclerosis Mitochondrial Changes within Axons in Multiple Sclerosis , 2022 .
[23] K. Blomgren,et al. X-linked inhibitor of apoptosis protein increases mitochondrial antioxidants through NF-kappaB activation. , 2007, Biochemical and biophysical research communications.
[24] P. Poulsen,et al. Low Birth Weight and Zygosity Status Is Associated With Defective Muscle Glycogen and Glycogen Synthase Regulation in Elderly Twins , 2007, Diabetes.
[25] L. Heilbronn,et al. Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. , 2007, The Journal of clinical endocrinology and metabolism.
[26] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[27] V. Ganapathy,et al. Down‐regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet , 2006, The Journal of physiology.
[28] Mei J. Zhu,et al. Maternal nutrient restriction affects properties of skeletal muscle in offspring , 2006, The Journal of physiology.
[29] C. Iadecola,et al. NF-κB Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91phox* , 2006, Journal of Biological Chemistry.
[30] C. Iadecola,et al. NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. , 2006, The Journal of biological chemistry.
[31] Mei J. Zhu,et al. Effect of Maternal Nutrient Restriction in Sheep on the Development of Fetal Skeletal Muscle1 , 2004, Biology of reproduction.
[32] W. Frontera,et al. IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.
[33] A. I. Rojo,et al. Regulation of Cu/Zn-Superoxide Dismutase Expression via the Phosphatidylinositol 3 Kinase/Akt Pathway and Nuclear Factor-κB , 2004, The Journal of Neuroscience.
[34] C. Hales,et al. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.
[35] K. Bhatia,et al. Type 2 (non-insulin-dependent) diabetes mellitus and HLA antigens in Papua New Guinea , 1984, Diabetologia.
[36] C. Osmond,et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth , 2004, Diabetologia.
[37] D. Winkler,et al. Telomeres shorten more slowly in long-lived birds and mammals than in short–lived ones , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[38] S. Oikawa,et al. Site‐specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening , 1999, FEBS letters.
[39] J. Boss,et al. Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB , 1997, Molecular and cellular biology.
[40] A. Lucas,et al. Organ-selective growth in the offspring of protein-restricted mothers , 1996, British Journal of Nutrition.
[41] J. Hoidal,et al. Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). , 1996, Genomics.
[42] S. Ozanne,et al. Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. , 1996, Biochemical Society transactions.
[43] N. Abraham,et al. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] A. Baldwin,et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.
[45] B. Reusens,et al. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. , 1990, Biology of the neonate.
[46] D. Barker,et al. WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE , 1989, The Lancet.